Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John de Groot

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Current Neurology and Neuroscience Reports|June 10, 2020
Neurologic Toxicities of Cancer Immunotherapies: a ReviewRebecca A Harrison, Sudhakar Tummala, John de Groot
Current Opinion in Neurology|October 1, 2019
The path forward for anti-programmed cell death-1 therapy in gliomasNazanin Majd, Carlos Kamiya-Matsuoka, John de Groot
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Antiangiogenic therapy for glioblastoma: the challenge of translating response rate into efficacyJohn de Groot, David A Reardon, Tracy T Batchelor
Molecular Cancer Therapeutics|February 5, 2009
Dasatinib-induced autophagy is enhanced in combination with temozolomide in gliomaVanessa Milano, Yuji Piao, Tiffany LaFortune, et al.
Hematology/Oncology Clinics of North America|November 20, 2019
Current Role of Radiation Therapy in the Management of Malignant Central Nervous System TumorsAhsan Farooqi, Jing Li, John de Groot, et al.
Anticancer Research|September 27, 2015
PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without VincristineCourtney Webre, Nicole Shonka, Lynette Smith, et al.
Oncology|November 20, 2008
Wernicke's encephalopathy: an underrecognized and reversible cause of confusional state in cancer patientsSheng-Han Kuo, J Mathew Debnam, Gregory N Fuller, et al.
Cancer Letters|October 16, 2010
Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studiesManmeet S Ahluwalia, John de Groot, Wei Michael Liu, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
The Promise of Poly(ADP-Ribose) Polymerase (PARP) Inhibitors in GliomasNazanin Majd, Timothy A Yap, W K Alfred Yung, et al.
Neurosurgical Review|May 22, 2026
The role of preoperative thrombocytic factors on survival in patients with glioblastoma: a meta-analysis and synopsis of the literatureYash Akkara, Joshua J Hon, Sruti Rehman, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Current Neurology and Neuroscience Reports|June 10, 2020
Neurologic Toxicities of Cancer Immunotherapies: a ReviewRebecca A Harrison, Sudhakar Tummala, John de Groot
Current Opinion in Neurology|October 1, 2019
The path forward for anti-programmed cell death-1 therapy in gliomasNazanin Majd, Carlos Kamiya-Matsuoka, John de Groot
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Antiangiogenic therapy for glioblastoma: the challenge of translating response rate into efficacyJohn de Groot, David A Reardon, Tracy T Batchelor
Molecular Cancer Therapeutics|February 5, 2009
Dasatinib-induced autophagy is enhanced in combination with temozolomide in gliomaVanessa Milano, Yuji Piao, Tiffany LaFortune, et al.
Hematology/Oncology Clinics of North America|November 20, 2019
Current Role of Radiation Therapy in the Management of Malignant Central Nervous System TumorsAhsan Farooqi, Jing Li, John de Groot, et al.
Anticancer Research|September 27, 2015
PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without VincristineCourtney Webre, Nicole Shonka, Lynette Smith, et al.
Oncology|November 20, 2008
Wernicke's encephalopathy: an underrecognized and reversible cause of confusional state in cancer patientsSheng-Han Kuo, J Mathew Debnam, Gregory N Fuller, et al.
Cancer Letters|October 16, 2010
Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studiesManmeet S Ahluwalia, John de Groot, Wei Michael Liu, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
The Promise of Poly(ADP-Ribose) Polymerase (PARP) Inhibitors in GliomasNazanin Majd, Timothy A Yap, W K Alfred Yung, et al.
Neurosurgical Review|May 22, 2026
The role of preoperative thrombocytic factors on survival in patients with glioblastoma: a meta-analysis and synopsis of the literatureYash Akkara, Joshua J Hon, Sruti Rehman, et al.
Pageof 9